SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-036476
Filing Date
2019-07-29
Accepted
2019-07-29 16:48:39
Documents
3
Period of Report
2019-07-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv526127_8k.htm 8-K 19262
2 EXHIBIT 99.1 tv526127_ex99-1.htm EX-99.1 2967
3 GRAPHIC image_001.jpg GRAPHIC 14832
  Complete submission text file 0001144204-19-036476.txt   44081
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 19981830
SIC: 2834 Pharmaceutical Preparations